RET51 (RET or CDHF12 or CDHR16) Antibody - Western Blot Validated

About the Target

Use this antibody to assess RET51 when mapping complex behavior and signaling context. RET51 is a regulator within kinase-driven cascades that influence transcriptional and metabolic responses. Many projects interpret this target alongside interacting partners, upstream cues, and downstream readouts.

Following RET51 across perturbations can help separate expression effects from compartment shifts.

Research Context

Signaling targets are typically assessed across time courses to capture transient activation windows. Considering complex membership and compartment shifts can clarify whether changes reflect signaling or redistribution. Developmental projects may follow this target across stage-dependent remodeling and tissue patterning.

Consider these angles when interpreting target-level changes:

• localization shifts between cytoplasm, membrane, and nucleus
• interaction patterns within multi-protein complexes
• condition-to-condition comparisons with matched controls

Variant Considerations

When samples are prepared in reducing conditions, some epitopes become more accessible; this version is designed with that context in mind. This matters because epitope exposure and background can vary with preparation and extraction steps. If you compare conditions, keep processing steps uniform to support clean interpretation.

If your study spans multiple model systems, it can help to define a shared reference condition for RET51 so cross-sample contrasts stay meaningful.

For challenging targets, pairing RET51 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

Choose the denaturing-format format to study RET51 in a way that stays anchored to pathway logic.